@erictopol.bsky.social
physician-scientist, author, editor https://www.scripps.edu/faculty/topol/ Ground Truths https://erictopol.substack.com SUPER AGERS https://www.simonandschuster.com/books/Super-Agers/Eric-Topol/9781668067666
@hannes-stark.bsky.social
MIT PhD Student - ML for biomolecules - https://hannes-stark.com/
@chaitjo.bsky.social
PhD student at University of Cambridge. Visitor at MRC LMB. Intern at FAIR, Meta & Prescient Design, Genentech. Interested in: 🔨 Deep learning: GNNs, Transformers and generative models. 🧬 Biomolecule design, especially RNA! https://chaitjo.com
@gcorso.bsky.social
PhD student @MIT • Research on Generative Models for Biophysics and Drug Discovery
@michaelwong.bsky.social
Biotech venture creation and pharma partnerships at Flagship Pioneering. Company builder by practice, placental biologist by training. 🇨🇦
@alexmorgan.bsky.social
Physician/scientist, partner at Khosla Ventures, investing in the future. 25 years of experience in the intersection of AI/ML, biotech and healthcare. Personal interests in art (painting, drawing, photography), sci-fi/fantasy, anthropology, and history.
@jelleprins.com
Designed the first apps for Uber.com, Booking.com, Catawiki.com and many others. Co-founder http://operator.exchange and http://cradle.bio
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine adunn@endpointsnews.com
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@kylelahucik.bsky.social
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
@leileiwu.bsky.social
reporting on drugs and biotechs @endpoints • email me: lwu@endpointsnews.com • Signal: leileiwu.24 • ✌️
@maxbayer.bsky.social
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or chat me for Signal. he/him
@nicolewetsman.bsky.social
deputy editor @endpts.com // formerly the verge & abc news // soccer posts
@shelbylivingston.bsky.social
Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers!
@jaredwhitlock.bsky.social
features editor @endpts.com / fall 2021 fellow @ksjatmit.bsky.social Writing (and editing) stories on rare disease medicine, diagnostics and China Reach out privately on Signal: jaredwhitlock.73
@nicoledefeudis.bsky.social
Biopharma reporter at Endpoints News | nicole@endpointsnews.com
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.